Immunology
1 drug is in development for Eosinophilic Esophagitis.
- Companies
- 1
- Clinical trials
- 9
BioSniper AIPage evidence connected
Prepared research question
Which programs lead the Eosinophilic Esophagitis pipeline—and what evidence could change the picture?
Run cited research
Traceable citations · Unknowns marked
Drug Pipeline by Phase
Phase 2(1)
| Drug | Company |
|---|---|
| etrasimod | ARENA PHARMACEUTICALS INC (ARNA) |
About this indication
Eosinophilic Esophagitis context
Immunology·MeSH: Eosinophilic Esophagitis (D057765)
Also known as: Chronic Esophagitides, Eosinophilic, Eosinophilic Chronic Esophagitis, Eosinophilic Esophagitides
Frequently asked questions
How many drugs are in development for Eosinophilic Esophagitis?
BioSniper tracks 1 drug in development for Eosinophilic Esophagitis across 1 company.
How many clinical trials target Eosinophilic Esophagitis?
There are 9 clinical trials targeting Eosinophilic Esophagitis tracked by BioSniper.